In a recent study, chromosomal engineering in mice showed that copy number gains in the Myc gene promote tumorigenesis in mammary tumors only if the downstream sequence encompassing Pvt1, Ccdc26, and Gsdmc is also amplified [39], suggesting that GSDMC may play a role in tumor progression. The gene discussed is MYC; the disease is neoplasm.